Valuation: Incyte Corporation

Market Cap 24.6B 21.66B 20.52B 18.53B 34.92B 2,358B 35.37B 246B 94.49B 1,206B 92.36B 90.35B 3,866B P/E 2026 *
54.9x
P/E 2027 * 16.7x
Enterprise Value 20.41B 17.97B 17.03B 15.37B 28.97B 1,957B 29.35B 204B 78.39B 1,000B 76.63B 74.96B 3,207B EV / Sales 2026 *
3.43x
EV / Sales 2027 * 2.98x
Free-Float
98.15%
Yield 2026 *
-
Yield 2027 * -
1 day-1.50%
1 week-2.64%
1 month-1.52%
3 months+7.05%
6 months+28.93%
Current year+22.86%
1 week 121.03
Extreme 121.03
126.14
1 month 119.97
Extreme 119.97
130
Current year 89.25
Extreme 89.25
132.6
1 year 82.82
Extreme 82.815
132.6
3 years 50.27
Extreme 50.27
132.6
5 years 50.27
Extreme 50.27
132.6
10 years 50.27
Extreme 50.27
153.15
Manager TitleAgeSince
Chief Executive Officer 58 2025-06-25
Director of Finance/CFO 57 2026-05-03
President 62 2023-06-04
Director TitleAgeSince
Chairman 59 2025-06-25
Director/Board Member 72 2015-01-19
Director/Board Member 64 2015-01-19
Date Insider Type Main position Quantity % Market Cap. Importance
9/22/26 Tax

Executive/Senior Manager

-920 0.0005%
9/15/26 Exercice

Chairperson

69,654 0.0344%
8/25/26 Tax

EVP, Human Resources

-504 0.0002%
Change 5-day change 1-year change 3-year change Capi.($)
-1.50%-2.64%+43.08%+110.06% 24.6B
-2.33%+0.53%+51.65%+115.42% 1,031B
-1.06%-1.65%+42.78%+69.98% 638B
-0.65%-1.32%+12.98%+75.49% 462B
-2.66%-1.87%+73.13%+41.15% 359B
-0.06%-3.88%+34.32%+39.39% 335B
-0.79%+2.01%+19.82%+27.79% 273B
-1.19%-1.21%+9.82%+10.61% 253B
-0.50%+3.80%+49.37%+56.84% 228B
-1.47%-1.53%+34.28%+98.89% 185B
Average -0.91%-0.59%+37.12%+64.56% 378.84B
Weighted average by Cap. -1.02%-0.36%+39.81%+71.46%

Financials

2026 *2027 *
Net sales 5.94B 5.23B 4.96B 4.48B 8.44B 570B 8.55B 59.33B 22.83B 291B 22.32B 21.83B 934B 6.27B 5.52B 5.23B 4.72B 8.89B 601B 9.01B 62.55B 24.07B 307B 23.53B 23.01B 985B
Net income 460M 405M 384M 347M 653M 44.11B 662M 4.59B 1.77B 22.55B 1.73B 1.69B 72.29B 1.5B 1.32B 1.25B 1.13B 2.13B 144B 2.16B 15B 5.77B 73.65B 5.64B 5.52B 236B
Net Debt -4.19B -3.69B -3.5B -3.16B -5.95B -402B -6.03B -41.83B -16.1B -205B -15.73B -15.39B -659B -5.95B -5.24B -4.97B -4.48B -8.45B -571B -8.56B -59.44B -22.87B -292B -22.36B -21.87B -936B
Logo Incyte Corporation
Incyte Corporation specializes in the research & development of therapeutic products mainly intended for the treatment of cancers and inflammatory disorders. Net sales break down by revenue source as follows: - product sales (84.7%); - royalties (12.4%); - income from research and cooperation agreements (2.9%).
Employees
2,844
Date Price Change Volume
26-09-30 US$121.35 -1.50% 1,619,920
26-09-29 US$123.20 -1.30% 1,718,561
26-09-28 US$124.82 +0.75% 1,436,282
26-09-25 US$123.89 -0.44% 1,210,055
26-09-24 US$124.44 -0.16% 1,404,535
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
121.35USD
Average target price
127.96USD
Spread / Average Target
+5.44%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. INCY Stock